Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion
Not Applicable
Completed
- Conditions
- Skin Irritation
- Interventions
- Other: Cetaphil Moisturizing Lotion Daily Advance
- Registration Number
- NCT01892423
- Lead Sponsor
- Galderma R&D
- Brief Summary
Human repeat insult patch test to assess the potential for Cetaphil Moisturizing Lotion Daily Advance to induce sensitization to the skin
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 146
Inclusion Criteria
- Age 18-65 years
- Good health
- willingness to cooperate and participate
- willingness to avoid topical products at test sites
- willingness to avoid direct sun exposure to test sites
Exclusion Criteria
- Individuals with active psoriasis or eczema
- individuals with sunburn, acne, abrasions, scar tissue, or tattoos on test sites, or disease of skin that might interfere
- individuals who have had a mastectomy with axillary nodes were removed
- individuals receiving anticancer, immunosuppressive treatments or medications, or radiation
- pregnant, nursing, or planned to become pregnant
- use of topical steroids or drugs at test sites
- active or untreated skin cancer
- active hepatitis
- current routine or frequent use of high doses of anti-inflammatory drugs
- individuals who have had les than two week rest period since completion of previous patch testing on upper back or upper arms
- individuals with uncontrolled metabolic diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Cetaphil Moisturizing Lotion Daily Advance Cetaphil Moisturizing Lotion Daily Advance Each subject had Cetaphil Moisturizing Lotion Daily Advance applied
- Primary Outcome Measures
Name Time Method Irritation responses average of 5 weeks all patients will be assessed at 14 visits for redness (erythema), spreading, weeping, papules, vesicles, and bullae at application site
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Cetaphil Moisturizing Lotion Daily Advance in preventing skin sensitization?
How does Cetaphil Moisturizing Lotion Daily Advance compare to other moisturizers in managing skin irritation?
Are there specific biomarkers that indicate individual response to Cetaphil Moisturizing Lotion Daily Advance in dermatological conditions?
What are the potential adverse events associated with Cetaphil Moisturizing Lotion Daily Advance and how are they managed in clinical settings?
What are the current research trends on combination therapies involving Cetaphil Moisturizing Lotion Daily Advance for skin irritation, and how does it relate to Galderma's other dermatological products?
Trial Locations
- Locations (1)
Thomas J Stephens and Associates Inc
🇺🇸Carrollton, Texas, United States